Skin Diseases, Infectious Completed Phase 2 Trials for Tigecycline (DB00560)

Also known as: Skin Disease, Infectious

IndicationStatusPhase
DBCOND0032714 (Skin Diseases, Infectious)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00488345Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of AgeTreatment